Socio-Geriatric Support for Aging Individuals
(ESOGER Trial)
Trial Summary
What is the purpose of this trial?
With the COVID-19 pandemic, elderly people (EP) living at home have seen their health deteriorated, thus increasing their needs in support and care. Indeed, while it was estimated that before the pandemic120 000 unattended living at home EP required care and services (taking bath, access to medication and food, etc.), the number doubled after COVID-19. Therefore, the waiting list for socio-medical services for unattended vulnerable clientele without a family doctor grew from 1300 à 1715 EP in a couple of months during the pandemic. With these numbers, it becomes clear that an intervention is needed. Truly, the Institut National d'Excellence en Santé et Services Sociaux (INESSS) conclude that it was pivotal to first identify the most vulnerable EP and second re-orient them according to their needs. Thus the investigator developed the Évaluation et orientation SOcio-GÉRiatrique (ESOGER) questionnaire available on a secure digital plateform enabling both a rapid evaluation and intervention to asses EP needs and provide the adequate ressources. Investigator's previous research has demonstrated that ESOGER is one of the rare clinical tools of first contact in telehealth while being global, multidimensional, and equitable. For this study, the investigator aims to evaluate the effect of ESOGER on EP physical and mental health, loss of autonomy, social isolation, quality of life and ressources consumption.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment ESOGER?
How is the treatment ESOGER different from other treatments for aging individuals?
ESOGER is unique because it focuses on evaluating and improving the social aspects of elderly individuals' lives, such as their social contacts, activities, and living conditions, which are crucial for their overall life satisfaction and well-being. Unlike traditional treatments that may focus solely on medical or physical health, ESOGER addresses the social environment and interactions, aiming to enhance the quality of life through a comprehensive socio-geriatric assessment.678910
Eligibility Criteria
This trial is for elderly people aged 65 or older living at home in the CCSMTL's Jeanne-Mance territory, who are experiencing varying degrees of frail health as indicated by a BGA score of 1/14 or more. It excludes those already in another trial, living outside the specified area, or unable to understand French or English.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants take the ESOGER questionnaire at month 0 and month 3, with the intervention group receiving recommendations based on their needs
Follow-up
Participants are monitored for changes in autonomy, socio-economic characteristics, quality of life, caregiver burden, COVID-19 symptoms, psychological frailty, and social health
Treatment Details
Interventions
- ESOGER
Find a Clinic Near You
Who Is Running the Clinical Trial?
Centre integre universitaire de sante et de services sociaux du Centre-Sud-de-l'Île-de-Montréal
Lead Sponsor